The Sheekey Science Show: NAD+ rejuvenation strategies

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

NAD+ metabolism in aging & three strategies to rejuvenate.

Welcome to The Sheekey Science Show!
Longevity.Technology is delighted to partner with YouTube sensation Eleanor Sheekey (interviewed here), who is kicking off with one of the hottest topics in the world of longevity supplements – NAD+.
Sheekey Science
NAD+ is one of the most important molecules in our bodies, however, levels have been shown to decline with age. Understanding NAD+ metabolism (how it is generated and consumed) can be quite complicated and it’s still being investigated, yet this understanding will help identify ways to rejuvenate levels of NAD+. One of the best ways to navigate the metabolism is to appreciate the structure and nomenclature of NAD+ and its precursors, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). As you will learn in this video, by understanding the different pathways through which NAD+ is made and used up, there are three strategies through which NAD+ levels could be rejuvenated.
Sheekey Science
You can think of the strategies as make, break or take. How you can enhance production (by activating NAMPT), how you can inhibit breaking down (eg. CD38 inhibitors such as apigenin) and how you can take (NAD+ precursors such as NMN, NR, niacin (NR) and NAM). The majority of work has been conducted in preclinical models, however as Eleanor explains, clinical trials are also in progress.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Phil Newman

Editor-in-Chief

Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Oura spends $625m to put doctors behind its smart ring

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE